Covered recipient · General Payments record
JEANETTE QABLAWI
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2022–2024
$1,070.63
- Reported across 35 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $515.55 | 18 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $201.73 | 6 |
| ABBVIE INC. | $170.18 | 7 |
| Exact Sciences Corporation | $65.62 | 2 |
| ViiV Healthcare Company | $32.51 | 1 |
| Gilead Sciences, Inc. | $26.93 | 1 |
| Novo Nordisk AS | $18.58 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $33.78 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105330413 | CMS |
| ABBVIE INC. | $22.00 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105330418 | CMS |
| ABBVIE INC. | $27.63 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105330422 | CMS |
| ABBVIE INC. | $31.43 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105330426 | CMS |
| ABBVIE INC. | $23.11 | 06/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105330430 | CMS |
| ABBVIE INC. | $1.94 | 06/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105330434 | CMS |
| ABBVIE INC. | $30.29 | 07/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105330438 | CMS |
| Exact Sciences Corporation | $33.26 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114842798 | CMS |
| Exact Sciences Corporation | $32.36 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114842792 | CMS |
| Gilead Sciences, Inc. | $26.93 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133749490 | CMS |
| Lilly USA, LLC | $19.08 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135056302 | CMS |
| Lilly USA, LLC | $122.08 | 07/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135034442 | CMS |
| Lilly USA, LLC | $19.25 | 08/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135007411 | CMS |
| Lilly USA, LLC | $25.53 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135007413 | CMS |
| Lilly USA, LLC | $2.18 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135034916 | CMS |
| Lilly USA, LLC | $13.61 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135035492 | CMS |
| Novo Nordisk Inc | $18.58 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096919416 | CMS |
| ViiV Healthcare Company | $32.51 | 11/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1112735173 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.